Protective Effect of Baogan Yihao on Acute and Chronic Hepatic Injury

HE Ping-ping; SONG Cong-cong; MENG Wei-wei; DENG Yu-lin; DAI Rong-ji; LIN Fan-kai; CHEN Yan; ZHAO Ying-hong; HUANG Yu-mei

您当前的位置：

首页 >

文章列表页 >

Protective Effect of Baogan Yihao on Acute and Chronic Hepatic Injury

更新时间：2024-01-04

- Protective Effect of Baogan Yihao on Acute and Chronic Hepatic Injury
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 2, Pages: 195-198(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
HE Ping-ping, SONG Cong-cong, MENG Wei-wei, et al. Protective Effect of Baogan Yihao on Acute and Chronic Hepatic Injury[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(2): 195-198.
DOI：

HE Ping-ping, SONG Cong-cong, MENG Wei-wei, et al. Protective Effect of Baogan Yihao on Acute and Chronic Hepatic Injury[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(2): 195-198. DOI：

摘要

目的: 探讨傣药保肝Ⅰ号(BGYH)对急慢性肝损伤的保护作用。方法: 采用iv卡介苗(BCG

1.5 × 107个活菌数/只)+脂多糖(LPS

10 μg/只)造成小鼠急性免疫性肝损伤模型

后连续ig保肝Ⅰ号低、中、高(5.1

10.2

20.4 g·kg-1)剂量12 d;采用iv刀豆蛋白(Con A

15 mg·kg-1)造成小鼠急性免疫性肝损伤模型

后连续ig保肝Ⅰ号低、中、高(5.1

10.2

20.4 g·kg-1)剂量7 d;采用sc CCl4(40%)大豆油溶液建立大鼠慢性肝纤维化模型

后连续ig保肝Ⅰ号低、中、高(0.14

0.28

0.56 g·kg-1)剂量8周。各组动物取血

测定血清谷丙转氨酶(ALT)和谷草转氨酶(AST)活力

并取肝脏做病理切片

观察肝组织病变

测定血清肿瘤坏死因子-α(TNF-α)

白蛋白(Alb)

测肝组织中羟脯氨酸(Hyp)含量。结果: 在BCG+LPS模型中

保肝Ⅰ号能显著降低ALT

AST活力和肝脏指数(HI);在 ConA模型中

保肝Ⅰ号能显著降低AST

ALT

TNF-α的活力;在CCl4复合因素诱导的大鼠慢性肝损伤模型中

保肝Ⅰ号能显著降低AST

ALT

升高Hyp

能显著升高Alb含量

且保肝Ⅰ号能减轻各模型动物肝脏病变。结论: 保肝Ⅰ号对急慢性肝损伤具有较好的保护作用。

Abstract

Objective: To investigate the protective effect of Dai medicine Baogan Yihao (BGYH) on acute and chronic liver injury. Method: Three kinds of animal model were established in this study. Acute model of immunological hepatic injury was established by iv Bacillus Calmetle-Guerin(BCG)+Lipopolysaccharide(LPS) in mouse

and ConA respectively. Rat model of chronic hepatic fibrosis was developed by ih of (CCl4). BGYH with high

medium and low doses were orally administrated. Activity of alanine aminotransferase (ALT) and spartate aminotransferase (AST) in serum was determined

and pathological changes in liver were also examined. Result: BGYH at the concentration of 20.4 g·kg-1 showed significantly inhibition on the acute immunological liver injury in mice induced by BCG+LPS and ConA; BGYH at the concentration of 0.56 g·kg-1 also inhibited the chronic hepatic fibrosis induced by CCl4 in rat model. And BGYH showed protection for hepatic lesions in animal models. Conclusion: BGYH can obviously protect acute and chronic liver injuries.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease：A Review

Clinical Efficacy of Gandou Fumu Granules in Intervention of Liver Fibrosis in WD Patients with Phlegm and Blood Stasis Syndrome and Effect on Cuproptosis-related Indicators

Gandouling Regulates PI3K/Akt/mTOR Autophagy Signaling Pathway via LncRNA H19 for Treatment of Wilson Disease Liver Fibrosis

Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β₁ Pathway

Related Author

HE Ping-ping1

SONG Cong-cong1

MENG Wei-wei1

DENG Yu-lin1

DAI Rong-ji1

LIN Fan-kai1

CHEN Yan2

ZHAO Ying-hong3

Related Institution

云南西双版纳州民族医药研究所

北京理工亘元医药技术开发中心有限公司

School of Life Science,Beijing Institute of Technology

Henan General Hospital

The First Affiliated Hospital of Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰